Application 022100
- Type
- NDA
- Sponsor
- DAIICHI SANKYO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AZOR | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | TABLET;ORAL | EQ 5MG BASE;20MG | Yes | No |
| 002 | AZOR | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | TABLET;ORAL | EQ 5MG BASE;40MG | Yes | No |
| 003 | AZOR | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | TABLET;ORAL | EQ 10MG BASE;20MG | Yes | No |
| 004 | AZOR | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | TABLET;ORAL | EQ 10MG BASE;40MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022100-001 | AZOR | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | EQ 5MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 |
| N022100-002 | AZOR | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | EQ 5MG BASE;40MG | TABLET / ORAL | AB | RLD | 2007-09-26 |
| N022100-003 | AZOR | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | EQ 10MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 |
| N022100-004 | AZOR | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | EQ 10MG BASE;40MG | TABLET / ORAL | AB | RLD, RS | 2007-09-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N022100-001 | AB |
| N022100-002 | AB |
| N022100-003 | AB |
| N022100-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022100-001 | AZOR | EQ 5MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022100-002 | AZOR | EQ 5MG BASE;40MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022100-003 | AZOR | EQ 10MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022100-004 | AZOR | EQ 10MG BASE;40MG | TABLET / ORAL | AB | RLD, RS | 2007-09-26 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N022100-001 | AZOR | EQ 5MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022100-002 | AZOR | EQ 5MG BASE;40MG | TABLET / ORAL | AB | RLD | 2007-09-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022100-003 | AZOR | EQ 10MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022100-004 | AZOR | EQ 10MG BASE;40MG | TABLET / ORAL | AB | RLD, RS | 2007-09-26 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022100-001 | AZOR | EQ 5MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022100-002 | AZOR | EQ 5MG BASE;40MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022100-003 | AZOR | EQ 10MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022100-004 | AZOR | EQ 10MG BASE;40MG | TABLET / ORAL | AB | RLD, RS | 2007-09-26 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022100-001 | AZOR | EQ 5MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022100-002 | AZOR | EQ 5MG BASE;40MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022100-003 | AZOR | EQ 10MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022100-004 | AZOR | EQ 10MG BASE;40MG | TABLET / ORAL | AB | RLD, RS | 2007-09-26 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022100-001 | AZOR | EQ 5MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022100-002 | AZOR | EQ 5MG BASE;40MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022100-003 | AZOR | EQ 10MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022100-004 | AZOR | EQ 10MG BASE;40MG | TABLET / ORAL | AB | RLD, RS | 2007-09-26 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022100-001 | AZOR | EQ 5MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022100-002 | AZOR | EQ 5MG BASE;40MG | TABLET / ORAL | AB | RLD | 2007-09-26 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022100-003 | AZOR | EQ 10MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022100-004 | AZOR | EQ 10MG BASE;40MG | TABLET / ORAL | AB | RLD, RS | 2007-09-26 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022100-001 | AZOR | EQ 5MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022100-002 | AZOR | EQ 5MG BASE;40MG | TABLET / ORAL | AB | RLD | 2007-09-26 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022100-003 | AZOR | EQ 10MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022100-004 | AZOR | EQ 10MG BASE;40MG | TABLET / ORAL | AB | RLD, RS | 2007-09-26 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022100-001 | AZOR | EQ 5MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022100-002 | AZOR | EQ 5MG BASE;40MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022100-003 | AZOR | EQ 10MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022100-004 | AZOR | EQ 10MG BASE;40MG | TABLET / ORAL | AB | RLD, RS | 2007-09-26 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022100-001 | AZOR | EQ 5MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022100-002 | AZOR | EQ 5MG BASE;40MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022100-003 | AZOR | EQ 10MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022100-004 | AZOR | EQ 10MG BASE;40MG | TABLET / ORAL | AB | RLD, RS | 2007-09-26 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022100-001 | AZOR | EQ 5MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022100-002 | AZOR | EQ 5MG BASE;40MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022100-003 | AZOR | EQ 10MG BASE;20MG | TABLET / ORAL | AB | RLD | 2007-09-26 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022100-004 | AZOR | EQ 10MG BASE;40MG | TABLET / ORAL | AB | RLD, RS | 2007-09-26 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022100-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022100-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022100-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022100-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N022100-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022100-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022100-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022100-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022100-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022100-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022100-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022100-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022100-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022100-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022100-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022100-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022100-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022100-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022100-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022100-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022100-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022100-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022100-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022100-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022100-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022100-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022100-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022100-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022100-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022100-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022100-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022100-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022100-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022100-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022100-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022100-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022100-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022100-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022100-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022100-004 | AB | 1 | 5bbf6a4d5a75… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| amlodipine besylate and olmesartan medoxomil | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | Golden State Medical Supply, Inc. | 132cca8f-48a2-2516-e063-6394a90a5f32 | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | 022100 NDA022100 |
| Azor | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | Cosette Pharmaceuticals, Inc. | c5535406-b63b-49aa-88b9-169aaf0ed08e | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 022100 NDA022100 0713-0872 0713-0871 0713-0873 0713-0870 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0713-0870 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 0713-0870 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 0713-0870 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 0713-0871 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 0713-0871 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 0713-0871 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 0713-0872 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 0713-0872 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 0713-0872 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 0713-0873 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 0713-0873 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 0713-0873 | Azor | amlodipine besylate and olmesartan medoxomil | Cosette Pharmaceuticals, Inc. | NDA | Current |
| 57664-772 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-772 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-772 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-772 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-772 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-773 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-773 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-773 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-773 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-773 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-774 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-774 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-774 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-774 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-774 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-775 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-775 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-775 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-775 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 57664-775 | Amlodipine and Olmesartan Medoxomil | amlodipine besylate and olmesartan medoxomil | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 65597-110 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-110 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-110 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-110 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-110 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-110 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-111 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-111 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-111 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-111 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-111 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-111 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-112 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-112 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-112 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-112 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-112 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-112 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-113 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-113 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-113 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-113 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-113 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
| 65597-113 | Azor | amlodipine besylate and olmesartan medoxomil | Daiichi Sankyo Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 64874 | SUPPL | 2020-10-07 |
| 64819 | SUPPL | 2020-10-05 |
| 46836 | SUPPL | 2017-01-13 |
| 46723 | SUPPL | 2017-01-06 |
| 46132 | SUPPL | 2016-12-13 |
| 45779 | SUPPL | 2016-11-02 |
| 45775 | SUPPL | 2016-11-01 |
| 16929 | SUPPL | 2014-09-26 |
| 6875 | SUPPL | 2014-09-24 |
| 38230 | SUPPL | 2014-07-03 |
| 6874 | SUPPL | 2014-07-03 |
| 6873 | SUPPL | 2014-06-18 |
| 38229 | SUPPL | 2014-06-17 |
| 38228 | SUPPL | 2013-07-05 |
| 6872 | SUPPL | 2013-07-05 |
| 38227 | SUPPL | 2012-12-13 |
| 6871 | SUPPL | 2012-12-11 |
| 29235 | SUPPL | 2012-10-03 |
| 16928 | SUPPL | 2012-10-02 |
| 38226 | SUPPL | 2012-01-23 |
| 29234 | SUPPL | 2012-01-20 |
| 29232 | SUPPL | 2011-11-16 |
| 38224 | SUPPL | 2011-11-14 |
| 29233 | SUPPL | 2011-11-03 |
| 38225 | SUPPL | 2011-10-31 |
| 6870 | SUPPL | 2011-05-24 |
| 6869 | SUPPL | 2011-05-24 |
| 38223 | SUPPL | 2011-05-23 |
| 16927 | SUPPL | 2011-05-23 |
| 21935 | ORIG | 2009-12-17 |
| 29230 | SUPPL | 2009-05-14 |
| 38222 | SUPPL | 2009-05-13 |
| 29231 | SUPPL | 2008-08-12 |
| 38221 | ORIG | 2007-10-04 |
| 6868 | ORIG | 2007-10-04 |